3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Dermatologic
1
Conditions
Melanoma
5
Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Diarrhea
3
Colitis
3
Carcinoma, Hepatocellular
3
Urogenital Neoplasms
2
Solid Carcinoma
2
Myelodysplastic Syndromes
2
Leukemia, Myeloid, Acute
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Vomiting
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Non Small Cell Lung Cancer Metastatic
1
Neoplasms, Plasma Cell
1
Nausea
1
Mesothelioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Interventions
Sunitinib
26
Everolimus
20
Bevacizumab
19
aldesleukin
18
Sorafenib
16
Nivolumab
16
Interleukin-2
14
pembrolizumab
13
Peripheral Blood Stem Cell Transplantation
13
fludarabine phosphate
12
Radiotherapy
12
Interferon-alpha
12
Cyclophosphamide
12
Radiosurgery
11
Filgrastim
11
Blood Specimen Collection
11
Ipilimumab
10
Gemcitabine
10
Axitinib
9
Surveys and Questionnaires
7
Gene Expression Profiling
7
Cryosurgery
7
temsirolimus
6
pazopanib
6
Surgical Procedures, Operative
6
durvalumab
5
cabozantinib
5
atezolizumab
5
Mycophenolic Acid
5
Immunohistochemistry
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Kidney Neoplasms
×
Fecal Microbiota Transplantation
×
Clear all
NCT06206707
2025-11-17
Immunobiome
University of Aarhus
Phase NA
Recruiting
20 enrolled